Ohcanbohtosat - Judith Hey‐Hadavi
- Čájehuvvo 1 - 3 / 3
-
1
-
2
Long-Term Safety of Pegvisomant in Patients with Acromegaly: Comprehensive Review of 1288 Subjects in ACROSTUDY Dahkki A. J. van der Lely, Beverly M. K. Biller, Thierry Brue, Michael Buchfelder, Ezio Ghigo, Roy Gomez, Judith Hey‐Hadavi, Frida Lundgren, Natasa Rajicic, Christian J. Strasburger, Susan M. Webb, Maria Kołtowska‐Häggström
Almmustuhtton 2012Artigo -
3
More than a decade of real-world experience of pegvisomant for acromegaly: ACROSTUDY Dahkki Maria Fleseriu, Dagmar Führer‐Sakel, A. J. van der Lely, Laura De Marinis, Thierry Brue, Joli van der Lans-Bussemaker, Judith Hey‐Hadavi, Cecilia Camacho‐Hübner, Michael P. Wajnrajch, Srinivas Rao Valluri, Andrew Palladino, Roy Gomez, Roberto Salvatori
Almmustuhtton 2021Artigo
Ohcanreaiddut:
Laktáseaddji fáttát
Internal medicine
Medicine
Acromegaly
Endocrinology
Growth hormone
Hormone
Pegvisomant
Adverse effect
Alternative medicine
Antibiotics
Antimicrobial
Biology
Bleeding on probing
Chemistry
Chronic periodontitis
Cohort
Diabetes mellitus
Doxycycline
Gastroenterology
Hemoglobin
Insulin
Magnetic resonance imaging
Metformin
Microbiology
Organic chemistry
Pathology
Pediatrics
Periodontitis
Placebo
Radiology